In this edition of our NCIA Committee Insights series originally aired on Wednesday, July 1, 2020 we were joined by members of our Scientific Advisory Committee for an overview of the Endocannabinoid System (ECS) in a manner that is easy for a general audience to understand.

Download the .PDF of the presentation here: http://bit.ly/3bqEAsl

After attending this webinar, you will have a greater understanding of the ECS, how cannabinoids interact with the ECS, and how cannabinoids in various products on the market are metabolized. A better understanding of these topics will equip budtenders and other industry staff with the knowledge to have more productive conversations about cannabis with customers and patients. Panelists also  discussed what budtenders should and should not say to customers and patients.

• Learning Objectives
  • To learn about the ECS, it’s components, and how cannabis products interact with it. 
  • To be able to explain why THC effects are delayed in edible products and almost immediate in inhalable products. 
  • To understand what you should and should not say to customers when promoting cannabis products to customers and patients.

Panelists:

Alena Rodriguez
Managing Director
Rm3 Labs

Ann Allworth
Founder & CEO
Cannabis Education Solutions

Tiffany Coleman
Director of Quality
Copperstate Farms Management

Cynthia Shelby-Lane
MD
Shelbylane MD PC

Paul Muchowski
Founder, CEO, CSO
Defined Research